KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection
Launched by UNIVERSITY OF EDINBURGH · Feb 11, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The KTRSensor Scotland Study is a research project aimed at understanding kidney transplant rejection better. This study will look at real-life experiences of patients who have received kidney transplants and are visiting their doctors for regular check-ups. Researchers want to find out if certain biological markers (substances in the body that can indicate health conditions) can help predict how well a transplant is doing and improve patient outcomes.
To participate in this study, you need to be a patient at a Scottish transplant center who has received a kidney transplant (and possibly a pancreas or islet transplant) and is scheduled for follow-up appointments. Unfortunately, if you have never had a kidney transplant before, are visiting a different clinic for follow-ups, or cannot provide urine samples during the study, you won't be eligible. Participants will help researchers collect important data that may lead to better monitoring and treatment for kidney transplant patients in the future.
Gender
ALL
Eligibility criteria
- • Any patient within a Scottish Transplant centre who has undergone renal transplant (+/- pancreas/islet) and is due to attend routine follow-up appointments at the index centre.
- Exclusion criteria:
- • no previous kidney transplant
- • patient attending follow-up at a peripheral site
- • unable to provide urine samples across the study duration
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glasgow, , United Kingdom
Edinburgh, , United Kingdom
Patients applied
Trial Officials
Marc Vendrell, PhD
Study Chair
University of Edinburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported